Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||2-Halomethyl derivatives of 2-amino acids|
|Abstract:||2-(Fluoromethyl or chloromethyl)-2,5-diaminopentanoic acid, 2-(fluoromethyl or chloromethyl)-2,6-diaminohexanoic acid, and 2-fluoromethyl-2-amino-5-guanidinopentanoic acid, and certain derivatives thereof, are inhibitors of ornithine decarboxylase. Methods of preparing the compounds and derivatives are also described.|
|Inventor(s):||Bey; Philippe (Strasbourg, FR), Jung; Michel (Illkirch-Graffenstaden, FR)|
|Assignee:||Merrell Dow France et Cie (Strasbourg, FR)|
|Filing Date:||Jan 27, 1988|
|Claims:||1. A method for preparing a compound of the formula: ##STR17## wherein n is 3 or 4; Y is --CH.sub.2 F or --CH.sub.2 Cl; which comprises: (a) treating a compound of the formula ##STR18## wherein n is as defined above, R' is (C.sub.1 -C.sub.8)alkoxy, R.sub.3 is hydrogen, phenyl, (C.sub.1 -C.sub.4)alkyl, methoxy or ethoxy, R.sub.4 is phenyl or (C.sub.1 -C.sub.4)alkyl, or R.sub.3 and R.sub.4 taken together form --CH.sub.2 --(CH.sub.2).sub.m --CH.sub.2 -- wherein m is an integer of from 3 to 5, and R.sub.2 is a group of the formula ##STR19## wherein R.sub.6 is phenyl, benzyl or (C.sub.1 -C.sub.4)alkyl and R.sub.3 and R.sub.4 are as defined above, |
with a strong base to form the corresponding carbanion;
(b) reacting the carbanion with an alkylating agent of the formula X.sub.1 CH.sub.2 X, wherein X.sub.1 is fluorine or chlorine and X is chlorine, bromine or iodine, in an aprotic solvent in the presence of hexamethylphosphoramide at a temperature of about -120.degree. C. to 120.degree. C. and a reaction time of about 1/2 hour to 48 hours; and
(c) hydrolyzing the alkylated product.
2. A method as defined in claim 1 for preparing 2-fluoromethyl-2,5-diaminopentanoic acid wherein the protected 2,5-diaminopentanoic acid employed in Step (a) is a (C.sub.1 -C.sub.8)alkyl ester of 2,5-bis(benzylideneamino)pentanoate, and the alkylating agent employed in Step (b) is chlorofluoromethane, bromofluoromethane, or iodofluoromethane.
3. A method as defined in claim 2 wherein the (C.sub.1 -C.sub.8)alkyl ester is the methyl ester.
4. A method as defined in claim 2 or 3 wherein the strong acid employed in Step (a) is sodium tert-butoxide and the alkylating agent employed in Step (b) is chlorofluoromethane.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.